VIATRIS INC. for VIATRIS INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Settlements, Patent Reform, S. 1720 Patent Transparency and Improvments Act of 2013, Patent Abuse Reduction Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Trade (domestic/foreign) TRD
General Trade Issues, TPP
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Taxation/Internal Revenue Code TAX
Tax Reform, Tax Extenders, Corporate Tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Health Issues HCR
Federal policy regarding Public Law 113-54, the Drug Quality and Security Act; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including BiologicalProducts," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics; Implementations of Biosimilars in the Affordable Care Act (ACA), Biosimilar Naming, Implementation of FDASIA and Generic Drug User Fee Act; The Generic Drug Pricing Transparency Act, H.R. 4437; Risk Evaluation Mitigation Strategies, Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK | — |
Budget/Appropriations BUD
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding; FY 2015 Budget, FY 2015 House and Senate Appropriations, Funding for FDA, Funding for the Office of Generic Drug, Generice Drug User Fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.